Gsk (GSK) Goodwill (2009 - 2026)

Gsk (GSK) has 18 years of Goodwill data on file, last reported at $9.9 billion in Q2 2026.

• For the quarter ending Q2 2026, Goodwill rose 10.24% year-over-year to $9.9 billion; the trailing twelve-month figure through Jun 2026 stood at $9.9 billion (up 10.24% YoY), and the FY2025 full-year result was $9.3 billion, up 4.6% from the prior year.
• Goodwill was $9.9 billion for Q2 2026 at Gsk, up from $9.8 billion in the prior quarter.
• In the past five years, Goodwill ranged from a high of $11.1 billion in Q1 2022 to a low of $7.4 billion in Q2 2022.
• A 5-year average of $8.9 billion and a median of $8.8 billion in 2024 frame the typical range for Goodwill.
• Across the five-year window, Goodwill plunged 49.01% in 2022 and advanced 13.0% in 2023, its largest moves.
• Gsk's Goodwill stood at $8.3 billion in 2022, then rose by 2.29% to $8.5 billion in 2023, then increased by 6.01% to $9.0 billion in 2024, then rose by 4.17% to $9.3 billion in 2025, then rose by 6.08% to $9.9 billion in 2026.
• Per Business Quant data, the three most recent Goodwill figures were $9.9 billion in Q2 2026, $9.8 billion in Q1 2026, and $9.3 billion in Q4 2025.